Bio-Techne Corp. insider trading
TECHfinancial statementsForm 4 filings on EDGAR118 transactions since Nov 3, 2024
From August 6, 2026 to November 3, 2026, 0 insiders at Bio-Techne Corp. bought $0 of stock in the open market, and 0 sold $0. Officers and directors accounted for $0 of purchases and $0 of sales. The last reported transaction was a tax withholding by Kelderman Kim on November 1, 2026.
The answer card and chart use the same period. Change the range above the chart to update both. Form 4 filings through November 3, 2026; awards, option exercises, tax withholding and gifts are excluded from these totals.
Stock price and insider activity
Daily price candles with insider purchases and sales directly beneath them on the same timeline. Bars show individual days; totals sum all days in the selected period.
Bought $0Sold $0Aug 6, 2026 – Nov 3, 2026
purchases above zero; sales below. Both use the transaction date and the same dollar scale. Hover, tap, or use arrow keys to inspect a date. Awards, exercises, tax withholding and gifts are excluded.
Dates with prices or insider activity are spaced evenly; empty weekends and holidays are omitted. Prices through Nov 3, 2026. Insider data through Nov 3, 2026. Prices are adjusted for splits; transaction values are reported dollars.
Every transaction
118 transactions from November 3, 2024 to November 3, 2026, newest first. Open-market purchases and sales are coloured; awards, exercises, tax withholding and gifts are grey and not counted.
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2026 | Kelderman Kim | Chief Executive Officer, Director | tax withholding | 2,385 | $72.66 | $173K | 80,509 | Nov 3, 2026 |
| Nov 1, 2026 | Hippel James | CFO | option exercise | 11,545 | $0.00 | — | 181,816 | Nov 3, 2026 |
| Nov 1, 2026 | Hippel James | CFO | tax withholding | 5,096 | $72.66 | $370K | 176,720 | Nov 3, 2026 |
| Oct 29, 2026 | Vessey Rupert | Director | award | 2,750 | $0.00 | — | 13,737 | Nov 2, 2026 |
| Oct 29, 2026 | Seth Alpna | Director | award | 2,750 | $0.00 | — | 18,161 | Nov 2, 2026 |
| Oct 29, 2026 | Klimovsky Judith V. | Director | award | 2,750 | $0.00 | — | 6,532 | Nov 2, 2026 |
| Oct 29, 2026 | Herr Amy E. | Director | award | 2,750 | $0.00 | — | 5,430 | Nov 2, 2026 |
| Oct 29, 2026 | Keegan Joseph D | Director | award | 2,750 | $0.00 | — | 18,161 | Nov 2, 2026 |
| Oct 29, 2026 | Higgins John L | Director | award | 2,750 | $0.00 | — | 80,004 | Nov 2, 2026 |
| Oct 29, 2026 | Bushman Julie L | Director | award | 2,750 | $0.00 | — | 11,525 | Nov 2, 2026 |
| Oct 29, 2026 | Baumgartner Robert V | Director | award | 2,750 | $0.00 | — | 59,634 | Nov 2, 2026 |
| Sep 28, 2026 | Higgins John L | Director | option exercise | 15,940 | $0.00 | — | 82,816 | Sep 30, 2026 |
| Sep 28, 2026 | Higgins John L | Director | tax withholding | 5,562 | $72.51 | $403K | 77,254 | Sep 30, 2026 |
| Sep 22, 2026 | Baumgartner Robert V | Director | option exercise | 15,940 | $0.00 | — | 62,443 | Sep 24, 2026 |
| Sep 22, 2026 | Baumgartner Robert V | Director | tax withholding | 5,559 | $72.55 | $403K | 56,884 | Sep 24, 2026 |
| Aug 15, 2026 | Hippel James | CFO | option exercise | 9,980 | $0.00 | — | 174,694 | Nov 2, 2026 |
| Aug 15, 2026 | Hippel James | CFO | tax withholding | 4,423 | $72.40 | $320K | 170,271 | Nov 2, 2026 |
| Aug 15, 2026 | Geist William | PRESIDENT, PROTEIN SCIENCES | option exercise | 6,547 | $0.00 | — | 27,050 | Nov 2, 2026 |
| Aug 15, 2026 | Geist William | PRESIDENT, PROTEIN SCIENCES | tax withholding | 2,019 | $72.40 | $146K | 25,031 | Nov 2, 2026 |
| Aug 15, 2026 | Kelderman Kim | Chief Executive Officer, Director | option exercise | 21,736 | $0.00 | — | 93,849 | Nov 2, 2026 |
| Aug 15, 2026 | Kelderman Kim | Chief Executive Officer, Director | tax withholding | 10,955 | $72.40 | $793K | 82,894 | Nov 2, 2026 |
| Aug 15, 2026 | Bohnen Shane | SVP - General Counsel | option exercise | 4,420 | $0.00 | — | 11,773 | Nov 2, 2026 |
| Aug 15, 2026 | Bohnen Shane | SVP - General Counsel | tax withholding | 1,366 | $72.40 | $99K | 10,407 | Nov 2, 2026 |
| Aug 15, 2026 | Kelderman Kim | Chief Executive Officer, Director | option exercise | 21,470 | $0.00 | — | 93,583 | Aug 18, 2026 |
| Aug 15, 2026 | Kelderman Kim | Chief Executive Officer, Director | tax withholding | 10,821 | $72.40 | $783K | 82,762 | Aug 18, 2026 |
| Aug 15, 2026 | Hippel James | CFO | option exercise | 9,779 | $0.00 | — | 174,493 | Aug 18, 2026 |
| Aug 15, 2026 | Hippel James | CFO | tax withholding | 4,310 | $72.40 | $312K | 170,183 | Aug 18, 2026 |
| Aug 15, 2026 | Geist William | PRESIDENT, PROTEIN SCIENCES | option exercise | 6,416 | $0.00 | — | 26,919 | Aug 18, 2026 |
| Aug 15, 2026 | Geist William | PRESIDENT, PROTEIN SCIENCES | tax withholding | 1,976 | $72.40 | $143K | 24,943 | Aug 18, 2026 |
| Aug 15, 2026 | Bohnen Shane | SVP - General Counsel | option exercise | 4,350 | $0.00 | — | 11,703 | Aug 18, 2026 |
| Aug 15, 2026 | Bohnen Shane | SVP - General Counsel | tax withholding | 1,343 | $72.40 | $97K | 10,360 | Aug 18, 2026 |
| Aug 15, 2026 | Crouse Steven C. | President - Diag & Spatial Bi | option exercise | 5,423 | $0.00 | — | 12,184 | Aug 18, 2026 |
| Aug 15, 2026 | Crouse Steven C. | President - Diag & Spatial Bi | tax withholding | 1,947 | $72.40 | $141K | 10,237 | Aug 18, 2026 |
| Aug 15, 2026 | Herr Amy E. | Director | option exerciseindirect | 589 | $0.00 | — | 789 | Aug 18, 2026 |
| Aug 15, 2026 | Herr Amy E. | Director | tax withholdingindirect | 213 | $72.40 | $15K | 576 | Aug 18, 2026 |
| Jul 29, 2026 | Hippel James | CFO | option exercise | 62,068 | $47.60 | $3M | 215,738 | Jul 31, 2026 |
| Jul 29, 2026 | Hippel James | CFO | tax withholding | 51,024 | $72.03 | $4M | 164,714 | Jul 31, 2026 |
| Jul 28, 2026 | Kelderman Kim | Chief Executive Officer, Director | option exercise | 35,000 | $47.60 | $2M | 100,799 | Jul 30, 2026 |
| Jul 28, 2026 | Kelderman Kim | Chief Executive Officer, Director | tax withholding | 28,686 | $72.07 | $2M | 72,113 | Jul 30, 2026 |
| Jul 23, 2026 | Bohnen Shane | SVP - General Counsel | option exercise | 448 | $47.60 | $21K | 7,697 | Jul 27, 2026 |
| Jul 23, 2026 | Bohnen Shane | SVP - General Counsel | tax withholding | 344 | $71.77 | $25K | 7,353 | Jul 27, 2026 |
| Jun 2, 2026 | Crouse Steven C. | President - Diag & Spatial Bi | option exercise | 600 | — | — | 6,977 | Jun 4, 2026 |
| Jun 2, 2026 | Crouse Steven C. | President - Diag & Spatial Bi | tax withholding | 216 | $49.77 | $11K | 6,761 | Jun 4, 2026 |
| May 8, 2026 | Herr Amy E. | Director | option exerciseindirect | 6,636 | $47.60 | $316K | 6,836 | May 12, 2026 |
| May 8, 2026 | Herr Amy E. | Director | open-market saleindirect | 6,636 | $48.28 | $320K | 200 | May 12, 2026 |
| May 5, 2026 | Hippel James | CFO | option exercise | 62,000 | $47.60 | $3M | 210,625 | May 7, 2026 |
| May 5, 2026 | Hippel James | CFO | tax withholding | 56,955 | $56.68 | $3M | 153,670 | May 7, 2026 |
| May 5, 2026 | Bohnen Shane | SVP - General Counsel | option exercise | 8,400 | $47.60 | $400K | 14,304 | May 7, 2026 |
| May 5, 2026 | Bohnen Shane | SVP - General Counsel | tax withholding | 7,055 | $56.68 | $400K | 7,249 | May 7, 2026 |
| May 5, 2026 | Kelderman Kim | Chief Executive Officer, Director | option exercise | 26,692 | $47.60 | $1M | 89,750 | May 7, 2026 |
Who the insiders are
Everyone who reported a transaction since November 3, 2024, by open-market value over twelve months. Shares held are after the insider’s latest directly held transaction.
| Insider | Role | Last transaction | Kind | Shares held | Bought, 12 months | Sold, 12 months | Sales under a plan |
|---|---|---|---|---|---|---|---|
| Herr Amy E. | Director | Oct 29, 2026 | award | 5,430 | — | $437K (2) | 0 of 2 |
| Kelderman Kim | Chief Executive Officer, Director | Nov 1, 2026 | tax withholding | 80,509 | — | — | — |
| Hippel James | CFO | Nov 1, 2026 | option exercise | 181,816 | — | — | — |
| Bohnen Shane | SVP - General Counsel | Aug 15, 2026 | option exercise | 11,773 | — | — | — |
| Geist William | PRESIDENT, PROTEIN SCIENCES | Aug 15, 2026 | option exercise | 27,050 | — | — | — |
| Higgins John L | Director | Oct 29, 2026 | award | 80,004 | — | — | — |
| Baumgartner Robert V | Director | Oct 29, 2026 | award | 59,634 | — | — | — |
| Crouse Steven C. | President - Diag & Spatial Bi | Aug 15, 2026 | option exercise | 12,184 | — | — | — |
| McManus Matthew | President - Diag & Spatial Bio | Feb 1, 2026 | option exercise | 9,356 | — | — | — |
| Vessey Rupert | Director | Oct 29, 2026 | award | 13,737 | — | — | — |
| Seth Alpna | Director | Oct 29, 2026 | award | 18,161 | — | — | — |
| Klimovsky Judith V. | Director | Oct 29, 2026 | award | 6,532 | — | — | — |
| Keegan Joseph D | Director | Oct 29, 2026 | award | 18,161 | — | — | — |
| Bushman Julie L | Director | Oct 29, 2026 | award | 11,525 | — | — | — |
| Nusse Roeland | Director | Aug 25, 2025 | option exercise | 61,599 | — | — | — |
Questions
Are Bio-Techne Corp. insiders buying or selling?
Over the twelve months to November 3, 2026, 1 insider at Bio-Techne Corp. sold $437K of stock in the open market, all by officers and directors, and no insider bought. Net, insiders sold $437K. Only open-market purchases and sales are counted.
Who sold the most Bio-Techne Corp. stock in the last year?
Herr Amy E. (Director) sold $437K in 2 open-market sales over the twelve months to November 3, 2026.
Do Bio-Techne Corp. executives sell under 10b5-1 plans?
0 of the 2 open-market sales in the last twelve months (0%) were reported as made under a Rule 10b5-1 trading plan, set up in advance. A sale under a plan is still counted as a sale.
What counts as insider buying here?
Only open-market purchases (Form 4 code P) and sales (code S) by officers, directors and 10% owners. Stock awards, option exercises, shares withheld for tax and gifts are listed in the table but never counted as buying or selling.
More on Bio-Techne Corp.
- Bio-Techne Corp. financial statements
- 1 tracked fund holding TECH
- Insider buying and selling across all companies
- These transactions as JSON
From Form 4, 4/A and 5 filings with the SEC. A record of insider transactions, not a recommendation.